目的探讨雷贝拉唑治疗幽门螺杆菌（HP）阳性消化性溃疡的效果及安全可靠性。
Objective To discuss the effect and safety of Rabeprazole in the treatment of peptic ulcer with infection of Helicobacter pylori(HP).
提示CAC可用于治疗HP阳性胃炎和消化性溃疡患者。
CAC can be used to treat both HP positive gastritis and digestive ulcer patients.
对幽门螺杆菌阳性的活动性胃炎及消化性溃疡进行抗幽门螺杆菌治疗已为大家所公认。
The value of HP eradication treatment in active chronic gastritis and peptic ulcers is now widely accepted.
在接受胃镜检查的520例受检者中，胃镜诊断为消化性溃疡、胃炎和胃癌的患者的呼气试验结果的阳性率分别为91.91%7、6.42%和62.07%。
The positive rates of peptic ulcer, gastritis and gastric carcinoma in the 520 patients examined by gastroscope were 91.91%, 76.42% and 62.07% respectively.
在接受胃镜检查的520例受检者中，胃镜诊断为消化性溃疡、胃炎和胃癌的患者的呼气试验结果的阳性率分别为91.91%7、6.42%和62.07%。
The positive rates of peptic ulcer, gastritis and gastric carcinoma in the 520 patients examined by gastroscope were 91.91%, 76.42% and 62.07% respectively.
应用推荐